The pathophysiological basis of acute-on-chronic liver failure.

The vast majority of patients that are referred to a specialist hepatological centre suffer from acute deterioration of their chronic liver disease. Yet, this entity of acute-on-chronic liver failure remains poorly defined. With the emergence of newer liver support strategies, it has become necessary to define this entity, its pathophysiology and the short and long-term prognosis. This review focuses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure. We briefly review the pathophysiological basis of the therapeutic modalities that are available. Our current strategy for the management of liver failure involves supportive therapy for the end-organs with the hope that the liver function would recover if sufficient time for such a recovery is allowed. Because liver failure, whether of the acute or acute-on-chronic variety, is potentially reversible, the stage is set for the application of newer liver support strategies to enhance the recovery process.

[1]  J. Henriksen,et al.  Hepatorenal Disorders: Role of the Sympathetic Nervous System , 1994, Seminars in liver disease.

[2]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[3]  T. Risler,et al.  Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  R. Jalan,et al.  The inflammatory basis of intracranial hypertension in acute liver failure. , 2001, Journal of hepatology.

[5]  M. Czaja,et al.  Lipopolysaccharide‐neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration , 1994, Hepatology.

[6]  A. Kohn.  Differential effects of isoleucine deprivation on cell motility, membrane transport and DNA synthesis in NIL 8 hamster cells. , 1975, Experimental cell research.

[7]  R. Miller,et al.  Branched-chain amino acid metabolism. , 1984, Annual review of nutrition.

[8]  C. Zauner,et al.  Partial pressure of ammonia versus ammonia in hepatic encephalopathy , 2000, Hepatology.

[9]  A. Pauwels,et al.  Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection , 1996, Hepatology.

[10]  O. Garden,et al.  Prediction of outcome following acute variceal haemorrhage , 1985, The British journal of surgery.

[11]  A. Bessman,et al.  THE RELATIVE EFFECTS OF ENTERICALLY ADMINISTERED PLASMA AND PACKED CELLS ON CIRCULATING BLOOD AMMONIA. , 1963, Gastroenterology.

[12]  R. Groszmann,et al.  Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. , 1997, The Journal of clinical investigation.

[13]  H. Volk,et al.  Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. , 1997, Gastroenterology.

[14]  W. Jiménez,et al.  Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.

[15]  E. Masini,et al.  Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis , 2001, Hepatology.

[16]  J. Biebuyck,et al.  Regional Blood‐Brain Barrier Permeability to Amino Acids After Portacaval Anastomosis , 1982, Journal of neurochemistry.

[17]  S. Moncada,et al.  The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat , 1993, British journal of pharmacology.

[18]  J. Licinio,et al.  Pathways and mechanisms for cytokine signaling of the central nervous system. , 1997, The Journal of clinical investigation.

[19]  T. Imperiale,et al.  Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. , 1997, Gastroenterology.

[20]  À. Rovira,et al.  The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. , 2001, Journal of hepatology.

[21]  L. Makowka,et al.  Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure , 1993, The Lancet.

[22]  T. Poynard,et al.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis , 1999, Hepatology.

[23]  J. Bosch,et al.  Complications of cirrhosis. I. Portal hypertension. , 2000, Journal of hepatology.

[24]  D. Häussinger,et al.  Hepatorenal reflex regulating kidney function , 1991, Hepatology.

[25]  P. Soeters,et al.  Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs , 1989, Hepatology.

[26]  P. Ott,et al.  Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration , 1999, Hepatology.

[27]  R. Williams,et al.  Primary sepsis presenting as fulminant hepatic failure. , 1989, The Quarterly journal of medicine.

[28]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[29]  V. Sørensen,et al.  Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[30]  Roger Williams,et al.  The systemic inflammatory response syndrome in acute liver failure , 2000, Hepatology.

[31]  V. Sørensen,et al.  Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute‐on‐chronic liver failure , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[32]  M. Salter,et al.  Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases , 1991, FEBS Letters.

[33]  K. Moore,et al.  Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. , 1991, Gastroenterology.

[34]  T. Maniatis,et al.  The nucleotide sequence of the human β-globin gene , 1980, Cell.

[35]  P. Hayes,et al.  Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. , 1997, Journal of hepatology.

[36]  D. Webb,et al.  Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. , 1998, Cardiovascular research.

[37]  H. Taniguchi,et al.  Increased intracranial pressure in a porcine model of fulminant hepatic failure using amatoxin and endotoxin. , 2001, Journal of hepatology.

[38]  L. Blendis,et al.  The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis. , 1998, Gastroenterology.

[39]  S. S. Lee,et al.  Increased nitric oxide synthase expression in aorta of cirrhotic rats. , 1999, Life sciences.

[40]  W. Reutter,et al.  Galactosamine-induced sensitization to the lethal effects of endotoxin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Hahn,et al.  Short‐term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems , 2001, Hepatology.

[42]  D. Annane,et al.  Compartmentalised inducible nitric-oxide synthase activity in septic shock , 2000, The Lancet.

[43]  M. Leist,et al.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. , 1995, The American journal of pathology.

[44]  K. Macnaul,et al.  Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[45]  R. Schrier,et al.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. , 1998, The Journal of clinical investigation.

[46]  C. Lieber.  Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. , 1997, Advances in pharmacology.

[47]  F. Marumo,et al.  Ischemic hepatitis in cirrhosis. clinical features and prognostic implications. , 1996, Journal of clinical gastroenterology.

[48]  D. Herndon,et al.  Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia , 1994, Critical care medicine.

[49]  F. Murad,et al.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors , 1993, British journal of pharmacology.

[50]  S. Moncada,et al.  Hyperdynamic circulation in cirrhosis: a role for nitric oxide? , 1991, The Lancet.

[51]  Intensive care unit admissions with cirrhosis: Risk‐stratifying patient groups and predicting individual survival , 1996, Hepatology.

[52]  R. Tobey,et al.  Isoleucine-mediated regulation of genome repliction in various mammalian cell lines. , 1971, Cancer research.

[53]  S. Mitzner,et al.  Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. , 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[54]  N. Deutz,et al.  Modification of the effects of blood on amino acid metabolism by intravenous isoleucine. , 1991, Gastroenterology.

[55]  R. Butterworth,et al.  Increased neuronal nitric oxide synthase expression in brain following portacaval anastomosis , 1997, Brain Research.

[56]  M. Epstein,et al.  Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis. , 1985, Mineral and electrolyte metabolism.

[57]  M. Sorrell,et al.  Cerebral oedema and increased intracranial pressure in chronic liver disease , 1998, The Lancet.

[58]  J. Clemmesen,et al.  Indomethacin normalizes intracranial pressure in acute liver failure: A twenty‐three‐year‐old woman treated with indomethacin , 1997 .

[59]  W. Konigsberg,et al.  The structure of human hemoglobin. IV. The chymotryptic digestion of the alpha chain of human hemoglobin. , 1962, The Journal of biological chemistry.

[60]  D. Webb,et al.  Altered peripheral vascular responses to exogenous and endogenous endothelin‐1 in patients with well‐compensated cirrhosis , 2001, Hepatology.

[61]  A. Blei,et al.  Cerebral blood flow and the development of ammonia‐induced brain edema in rats after portacaval anastomosis , 1999, Hepatology.

[62]  G. Bleichner,et al.  Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage , 1986, The British journal of surgery.

[63]  K. Morris,et al.  Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats , 1996, Hepatology.

[64]  S. Moncada,et al.  Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. , 1995, European journal of pharmacology.

[65]  L. Rodrigo,et al.  Presence of Bacterial Infection in Bleeding Cirrhotic Patients Is Independently Associated with Early Mortality and Failure to Control Bleeding , 2001, Digestive Diseases and Sciences.